公司資料

Sharps Technology 股價、新聞與催化劑

股票代碼:
STSS
交易所:
NASDAQ
產業:
Biopharma
所在地:
United States

股票表現

1.84 USD (+1.10%)

收盤價

最後更新: 2026年5月27日

77.9M USD

市值

股價為何變動

Current closing-price context is not available for STSS.

公司概覽

業務概覽

Sharps Technology is a medical device company focused on safer syringes and drug-delivery safety products. Its business is built around reducing contamination and improving handling in injectable workflows.

所在地與產業分類

Sharps Technology is headquartered in the United States and listed on NASDAQ. It sits in medical devices and drug-delivery hardware rather than biotechnology.

商業模式特徵

The company depends on product adoption, regulatory progress, and the ability to scale its device platform into healthcare channels. Investors watch sales execution and manufacturing readiness.

生技產業定位

Sharps Technology is part of the medical-device safety layer of healthcare. It is not biotech, but it matters to the injection and drug-delivery ecosystem.

未來催化劑

  • Sharps Technology’s catalysts are prefilled syringe and medication-delivery execution, plus any operating update that clarifies whether the company can keep scaling. The market will care about real commercial demand.

近期新聞

    相似股票

    商業成熟度、治療領域或催化劑模式相近的同業公司。